This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene (CNC) Beats Q1 Earnings and Revenues
by Zacks Equity Research
Centene (CNC) came out with operating earnings of $2.17 per share, which beat the Zacks Consensus Estimate of $1.92.
Zacks.com featured expert Kevin Matras highlights: Visa, Graco, Centene and Arch Coal
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Visa, Graco, Centene and Arch Coal
Winning Stock Picks from the Top 4 Industries with the Biggest Job Growth
by Kevin Matras
Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include V, GGG, CNC and ARCH.
GNC Holdings Partners Rapid Nutrition, Forays in Australia
by Zacks Equity Research
GNC Holdings' (GNC) tie-up with Rapid Nutrition is likely to fuel the company's entry and expansion into the Australian healthcare market.
Stryker Loses 7.6% in a Month: What's Weighing It Down?
by Zacks Equity Research
Stryker's (SYK) declining margins and demand for healthcare products raise concern.
Bull of the Day: Centene (CNC)
by Kevin Cook
Despite doubts about ACA reform and the Fidelis Care acquisition, analysts just vaulted EPS estimates over 20%
Cooper (COO) Buys LifeGlobal to Widen Fertility Device Line
by Zacks Equity Research
Cooper Companies' (COO) LifeGlobal asset purchase is likely to boost CooperSurgical.
The Zacks Analyst Blog Highlights: Centene, Western Digital, Concho Resources, Pioneer Natural Resources and Tyson Foods
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Western Digital, Concho Resources, Pioneer Natural Resources and Tyson Foods
Could April be a Better Month for Stocks? 5 Large-Cap Picks
by Swarup Gupta
Historical data shows that the Dow has gained 1.9% on average during April since 1950.
Seagate Technology, Cadence Design Systems, NVIDIA, Micron and Centene highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Seagate Technology, Cadence Design Systems, NVIDIA, Micron and Centene highlighted as Zacks Bull and Bear of the Day
Time to Learn from the Facts: Global Week Ahead
by Mark Vickery
Bond market economists and stock strategists alike consider the huge flow of macro data out in the first week of a month ??? particularly payrolls in the USA, inflation in Europe, and manufacturing PMIs everywhere ??? to be catalysts for changes to their quarterly and annual outlooks, on rates and on stock prices, respectively.
Zacks.com highlights: Pioneer Natural Resources, Centene, Mammoth Energy Services, Stoneridge and FTI Consulting
by Zacks Equity Research
Zacks.com highlights: Pioneer Natural Resources, Centene, Mammoth Energy Services, Stoneridge and FTI Consulting
The Zacks Analyst Blog Highlights: Facebook, Centene, Nitto Denko and TIM Participacoes SA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, Centene, Nitto Denko and TIM Participacoes SA
Here's Why You Should Steer Clear of DENTSPLY (XRAY) for Now
by Zacks Equity Research
DENTSPLY SIRONA (XRAY) faces foreign exchange woes and chances of margin decline in the quarters ahead.
Enhance Your Returns With 5 Relative Price Strength Stocks
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
More Angst About Facebook: Global Week Ahead
by John Blank
It looks like a quiet Global Week Ahead. This happens towards the end of any month. These are, for the most part, a continuation of worries that surfaced in recent weeks. Nothing is 'new' news.
Zacks.com featured highlights include: Dine Brands, Builders FirstSource, Centene, Encore Wire and HFF
by Zacks Equity Research
Zacks.com featured highlights include: Dine Brands, Builders FirstSource, Centene, Encore Wire and HFF
5 Best Momentum Stocks to Buy Using Driehaus Strategy
by Zacks Equity Research
Investors with a high risk appetite might give the Driehaus strategy a thought to boost returns.
New Strong Buy Stocks for March 21st
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
5 Reasons Why Centene is an Attractive Bet for Investors
by Zacks Equity Research
Centene (CNC) can be considered a lucrative investment option on the back of top-line growth, inorganic strategies and a solid financial health.
Should Value Investors Pick Centene Corporation (CNC) Stock?
by Zacks Equity Research
Let's put Centene Corporation (CNC) stock into this equation and find out if it is a good choice for value-oriented investors right now.
Centene Makes Investment in RxAdvance, Builds Partnership
by Zacks Equity Research
Centene's (CNC) transformative alliance with RxAdvance is another instance of Health insurers joining forces with pharmacy benefit managers to reduce the costs in the drug supply chain.
Cigna on Raters' Radar After Express Scripts Bid, Stock Down
by Zacks Equity Research
Cigna (CI) gets rating downgrade on a number of concerns related to the Express Scripts deal.
5 Top Stocks to Make the Most of March Madness
by Tirthankar Chakraborty
March Madness tournaments mostly concur with strong stock gains. The phenomenon starts from the second week of March and lasts through the first week of April.
Shrug Off Market Gyrations With These Top 5 Value Picks
by Zacks Equity Research
Despite a recovery from recent correction, several concerns plague the investors. A global trade war, hike in interest rate and an inflationary tendency in the U.S. economy are major near-term concerns.